Search Results 61-70 of 17300 for egfr
Cohort C: Subjects with primary EGFR mutated disease, with a documented EGFR ... Previous treatment with an EGFR TKI with activity against EGFR Exon 20 insertions ...
... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...
* Male and female patients ≥ 18 years of age with an eGFR level and biopsy-confirmed IgA nephropathy as follows: * For patients eGFR\* ≥ 45ml/min/1.73m2 ...
Currently being evaluated for kidney transplant (eGFR < 20ml/min). Exclusion Criteria (Aim 1 & 2): Women who are currently pregnant. Prior history of ...
... EGFR TKIs, such as erlotinib, gefitinib, or another EGFR TKI appropriate for the treatment of EGFR-mutant NSCLC. Patients known to have an ALK fusion ...
The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express epidermal growth factor receptor (EGFR).
Therefore, many health care professionals rely on calculated estimates of the glomerular filtration rate known as eGFR. This estimate is important because ...
Your doctor uses your estimated glomerular filtration rate (eGFR) to measure your level of kidney function. Your eGFR is calculated using your blood ...
Histologically or cytologically confirmed locally advanced or metastatic EGFRm+ NSCLC harbouring an EGFR mutation known to be associated with EGFR TKI ...
... (eGFR) decline in patients at risk of ... *Eligibility will be confirmed by eGFR value from one of the two first pre-randomization eGFR measurements.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.